Bayer AG Beats Earnings Estimates and Reaffirms FY26 Outlook
Bayer AG reported better-than-expected profit in the second quarter, driven by a strong performance in its crop science business, and reaffirmed its full-year 2026 outlook.
Results for "Bayer AG"
7 stories found
Bayer AG (BAYRY) Receives FDA Approval For Expanded MR Injector Application
Bayer Offers $7.25 Billion to Settle Roundup Weedkiller Cancer Claims
Bayer has offered $7.25 billion to resolve long-standing legal battles over its Roundup weedkiller, which has been linked to cancer.
Bayer Agrees to Pay $133 Million for PCB Cleanup in Michigan and Rhode Island
Bayer has reached an agreement to pay $133 million for the cleanup of PCB contamination in affected areas of Michigan and Rhode Island.
MDA Space Reports Strong Q4 Earnings and Revenue, Introduces FY26 Outlook
MDA Space announced Non-GAAP EPS of C$0.45 and revenue of C$499.1 million, surpassing expectations, and provided its financial outlook for fiscal year 2026.
Diverse Companies Announce Q1/Q2 2026 Earnings Previews and Results
Multiple companies, including Atour Lifestyle Holdings and National Vision Holdings, are either previewing their Q1 and Q2 2026 financial results or have already reported their GAAP EPS and revenue. This cluster covers a range of corporate earnings updates for the specified quarters.
Bayer Agrees to Billions in Roundup Lawsuit Settlements
German chemical giant Bayer has reached a proposed $7.25 billion settlement over lawsuits claiming that glyphosate in its Roundup weedkiller causes cancer.